Literature DB >> 32286242

The value of urine biochemical parameters in the prediction of the severity of coronavirus disease 2019.

Rui Liu1, Qingfeng Ma2, Huan Han1, Hanwen Su1, Fang Liu3,4, Kailang Wu3, Wei Wang5, Chengliang Zhu1.   

Abstract

Background Among patients with coronavirus disease 2019 (COVID-19), the cases of a significant proportion of patients are severe. A viral nucleic acid test is used for the diagnosis of COVID-19, and some hematological indicators have been used in the auxiliary diagnosis and identification of the severity of COVID-19. Regarding body fluid samples, except for being used for nucleic acid testing, the relationship between COVID-19 and routine body fluid parameters is not known. Our aim was to investigate the value of urine biochemical parameters in the prediction of the severity of COVID-19. Methods A total of 119 patients with COVID-19 were enrolled at Renmin Hospital of Wuhan University. According to the severity of COVID-19, the patients were divided into three groups (moderate 67, severe 42 and critical 10), and 45 healthy persons were enrolled in the same period as healthy controls. The relationship between the results of urine biochemical parameters and the severity of COVID-19 was analyzed. Results The positive rates of urine occult blood (BLOOD) and proteinuria (PRO) were higher in COVID-19 patients than in healthy controls (p < 0.05); the urine specific gravity (SG) value was lower in patients than in healthy controls (p < 0.05), and the urine potential of hydrogen (pH) value was higher in patients than in healthy controls (p < 0.01). The positive rates of urine glucose (GLU-U) and PRO in the severe and critical groups were higher than those in the moderate group (p < 0.01 and p < 0.05, respectively); other biochemical parameters of urine were not associated with the severity of COVID-19. Conclusions Some urine biochemical parameters are different between patients with severe acute respiratory syndrome (SARS)-CoV-2 and healthy controls, and GLU-U and PRO may be helpful for the differentiation of COVID-19 severity.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; urine biochemical parameters

Mesh:

Substances:

Year:  2020        PMID: 32286242     DOI: 10.1515/cclm-2020-0220

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  26 in total

1.  Association of AKI-D with Urinary Findings and Baseline eGFR in Hospitalized COVID-19 Patients.

Authors:  Dipal M Patel; Manali Phadke; Feng Dai; Michael Simonov; Neera K Dahl; Ravi Kodali
Journal:  Kidney360       Date:  2021-05-20

2.  Plasma Levels and Renal Handling of Amino Acids Contribute to Determination of Risk of Mortality or Feed of Ventilation in Patients with COVID-19.

Authors:  Gábor Bánfai; Péter Kanizsai; Csaba Csontos; Szilárd Kun; Ágnes Lakatos; Anikó Lajtai; Vanessza Lelovics; Sándor Szukits; Péter Bogner; Attila Miseta; István Wittmann; Gergő A Molnár
Journal:  Metabolites       Date:  2022-05-27

3.  A Retrospective Cohort Study on the Clinical Course of Patients With Moderate-Type COVID-19.

Authors:  Xiaohua Liao; Xin Lv; Cheng Song; Mao Jiang; Ronglin He; Yuanyuan Han; Mengyu Li; Yan Zhang; Yupeng Jiang; Jie Meng
Journal:  Front Public Health       Date:  2021-04-26

Review 4.  Solid Organ Transplantation During the COVID-19 Pandemic.

Authors:  Hedong Zhang; Helong Dai; Xubiao Xie
Journal:  Front Immunol       Date:  2020-06-16       Impact factor: 7.561

5.  Urine biomarkers for the prediction of mortality in COVID-19 hospitalized patients.

Authors:  Daniel Morell-Garcia; David Ramos-Chavarino; Josep M Bauça; Paula Argente Del Castillo; Maria Antonieta Ballesteros-Vizoso; Luis García de Guadiana-Romualdo; Cristina Gómez-Cobo; J Albert Pou; Rocío Amezaga-Menéndez; Alberto Alonso-Fernández; Isabel Llompart; Ana García-Raja
Journal:  Sci Rep       Date:  2021-05-27       Impact factor: 4.379

6.  Is coronavirus disease 2019 associated with indicators of long-term bladder dysfunction?

Authors:  Blayne Welk; Lucie Richard; Emmanuel Braschi; Marcio A Averbeck
Journal:  Neurourol Urodyn       Date:  2021-05-04       Impact factor: 2.696

7.  Urine Biochemical Parameters in Predicting Severity of SARS-CoV-2 Infection: an Experience in Tertiary Care Centre in Western India.

Authors:  Priyanka Murgod; Preeti Doshi; Ravindra Nimbargi
Journal:  Iran J Pathol       Date:  2021-06-12

8.  Manifestations of renal system involvement in hospitalized patients with COVID-19 in Saudi Arabia.

Authors:  Khaled S Allemailem; Ahmad Almatroudi; Amjad Ali Khan; Arshad H Rahmani; Ibrahim S Almarshad; Fahad S Alekezem; Nagwa Hassanein; Asmaa M El-Kady
Journal:  PLoS One       Date:  2021-07-15       Impact factor: 3.240

9.  Routine laboratory testing to determine if a patient has COVID-19.

Authors:  Inge Stegeman; Eleanor A Ochodo; Fatuma Guleid; Gea A Holtman; Bada Yang; Clare Davenport; Jonathan J Deeks; Jacqueline Dinnes; Sabine Dittrich; Devy Emperador; Lotty Hooft; René Spijker; Yemisi Takwoingi; Ann Van den Bruel; Junfeng Wang; Miranda Langendam; Jan Y Verbakel; Mariska Mg Leeflang
Journal:  Cochrane Database Syst Rev       Date:  2020-11-19

10.  COVID-19 laboratory testing issues and capacities as we transition to surveillance testing and contact tracing.

Authors:  Brendon Sen-Crowe; Mark McKenney; Adel Elkbuli
Journal:  Am J Emerg Med       Date:  2020-05-27       Impact factor: 2.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.